3.29
0.22 (7.17%)
| Penutupan Terdahulu | 3.07 |
| Buka | 3.05 |
| Jumlah Dagangan | 623,533 |
| Purata Dagangan (3B) | 537,131 |
| Modal Pasaran | 226,511,728 |
| Harga / Jualan (P/S) | 1.95 |
| Harga / Buku (P/B) | 0.670 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Aug 2026 |
| Margin Keuntungan | -19.77% |
| Margin Operasi (TTM) | -61.02% |
| EPS Cair (TTM) | -0.420 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -44.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 3.58% |
| Nisbah Semasa (MRQ) | 12.34 |
| Aliran Tunai Operasi (OCF TTM) | 27.37 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 12.04 M |
| Pulangan Atas Aset (ROA TTM) | -4.80% |
| Pulangan Atas Ekuiti (ROE TTM) | -7.77% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Menaik | Bercampur | |
| Stok | OraSure Technologies, Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | 0.0 |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | 4.0 |
| Purata | 0.13 |
|
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 4.83% |
| % Dimiliki oleh Institusi | 89.49% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Private Management Group Inc | 31 Mar 2026 | 5,422,129 |
| Altai Capital Management, L.P. | 31 Mar 2026 | 3,613,836 |
| Cannell Capital Llc | 31 Mar 2026 | 2,003,271 |
| Kotler Kevin | 31 Dec 2025 | 1,801,446 |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| BERTRAND JOHN D. | 2.97 | - | 33,661 | 99,973 |
| BOYD STEVEN KYLE | 2.99 | - | 75,000 | 224,000 |
| GAGLIANO NANCY J | - | 3.04 | -21,305 | -64,767 |
| MARMORA LELIO | - | 3.04 | -28,406 | -86,354 |
| MCMAHON ROBERT W. | - | 3.04 | -22,888 | -69,580 |
| Jumlah Keseluruhan Kuantiti Bersih | 36,062 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 103,272 | |||
| Purata Pembelian Keseluruhan ($) | 2.98 | |||
| Purata Jualan Keseluruhan ($) | 3.04 | |||
| Julat Insider ($) | ||||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| BOYD STEVEN KYLE | Pengarah | 14 May 2026 | Beli (+) | 25,000 | 2.95 | 73,750 |
| GAGLIANO NANCY J | Pengarah | 13 May 2026 | Dibuang (-) | 21,305 | 3.04 | 64,767 |
| MCMAHON ROBERT W. | Pengarah | 13 May 2026 | Dibuang (-) | 22,888 | 3.04 | 69,580 |
| MARMORA LELIO | Pengarah | 13 May 2026 | Dibuang (-) | 28,406 | 3.04 | 86,354 |
| BOYD STEVEN KYLE | Pengarah | 13 May 2026 | Beli (+) | 25,000 | 3.04 | 76,000 |
| BERTRAND JOHN D. | Pengarah | 12 May 2026 | Diperolehi (+) | 33,661 | 2.97 | 99,973 |
| BOYD STEVEN KYLE | Pengarah | 12 May 2026 | Beli (+) | 25,000 | 2.97 | 74,250 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |